Cedar Brook Financial Partners, LLC Abbott Laboratories Transaction History

Cedar Brook Financial Partners, LLC

$698 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$109.52 - $120.96 $63,083 - $69,672	576 Added 11.2%	5,721 $650,000
Q4 2023 Jan 12, 2024	SELL	$90.19 - $110.4 $6,854 - $8,390	-76 Reduced 1.46%	5,145 $566,000
Q3 2023 Oct 17, 2023	BUY	$95.53 - $114.62 $81,200 - $97,427	850 Added 19.45%	5,221 $505,000
Q2 2023 Jul 05, 2023	BUY	$100.78 - $112.29 $302 - $336	3 Added 0.07%	4,371 $476,000
Q1 2023 Apr 04, 2023	SELL	$96.86 - $114.01 $3,196 - $3,762	-33 Reduced 0.75%	4,368 $442,000
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $13,593 - $15,947	-143 Reduced 3.15%	4,401 $483,000
Q3 2022 Jan 03, 2023	BUY	$96.76 - $112.03 $12,385 - $14,339	128 Added 2.9%	4,544 $439,000
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $23,374 - $28,251	229 Added 5.47%	4,416 $480,000
Q1 2022 Apr 06, 2022	BUY	$114.02 - $139.04 $85,971 - $104,836	754 Added 21.96%	4,187 $496,000
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $31,308 - $38,335	271 Added 8.57%	3,433 $483,000
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $28,465 - $31,490	-244 Reduced 7.16%	3,162 $374,000
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $47,605 - $56,038	450 Added 15.22%	3,406 $395,000
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $85,657 - $100,917	-787 Reduced 21.03%	2,956 $354,000
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $55,440 - $60,413	528 Added 16.42%	3,743 $410,000
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $16,220 - $19,698	-177 Reduced 5.22%	3,215 $349,000
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $21,592 - $27,636	-282 Reduced 7.68%	3,392 $310,000
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $41,963 - $61,362	668 Added 22.22%	3,674 $290,000
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $6,673 - $7,429	85 Added 2.91%	3,006 $261,000
Q3 2019 Oct 24, 2019	BUY	$81.84 - $88.74 $239,054 - $259,209	2,921 New	2,921 $244,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account